Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aminocaproic acid | The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Kallidinogenase. |
| Alpha-1-proteinase inhibitor | Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Kallidinogenase. |
| Menadione | Menadione may increase the thrombogenic activities of Kallidinogenase. |
| Tranexamic acid | Tranexamic acid may increase the thrombogenic activities of Kallidinogenase. |
| Aprotinin | Aprotinin may increase the thrombogenic activities of Kallidinogenase. |
| Hydrogen peroxide | Hydrogen peroxide may increase the thrombogenic activities of Kallidinogenase. |
| Aminomethylbenzoic acid | Aminomethylbenzoic acid may increase the thrombogenic activities of Kallidinogenase. |
| Camostat | Camostat may increase the thrombogenic activities of Kallidinogenase. |
| Menadione bisulfite | Menadione bisulfite may increase the thrombogenic activities of Kallidinogenase. |
| Monteplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Monteplase. |
| Lepirudin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin. |
| Bivalirudin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Bivalirudin. |
| Alteplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Alteplase. |
| Urokinase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Urokinase. |
| Reteplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Reteplase. |
| Anistreplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Anistreplase. |
| Tenecteplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tenecteplase. |
| Abciximab | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Abciximab. |
| Drotrecogin alfa | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Drotrecogin alfa. |
| Streptokinase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Streptokinase. |
| Dicoumarol | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dicoumarol. |
| Argatroban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Argatroban. |
| Ardeparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ardeparin. |
| Phenindione | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Phenindione. |
| Fondaparinux | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Fondaparinux. |
| Warfarin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Warfarin. |
| Pentosan polysulfate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Pentosan polysulfate. |
| Phenprocoumon | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Phenprocoumon. |
| Dipyridamole | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dipyridamole. |
| Heparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Heparin. |
| Enoxaparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Enoxaparin. |
| Epoprostenol | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Epoprostenol. |
| Acenocoumarol | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Acenocoumarol. |
| 4-hydroxycoumarin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with 4-hydroxycoumarin. |
| Coumarin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Coumarin. |
| Ximelagatran | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ximelagatran. |
| Desmoteplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Desmoteplase. |
| Defibrotide | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Defibrotide. |
| Ancrod | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ancrod. |
| Beraprost | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Beraprost. |
| Prasugrel | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Prasugrel. |
| Rivaroxaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Rivaroxaban. |
| Sulodexide | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Sulodexide. |
| Idraparinux | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Idraparinux. |
| Cangrelor | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Cangrelor. |
| Astaxanthin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Astaxanthin. |
| Apixaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Apixaban. |
| Otamixaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Otamixaban. |
| Amediplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Amediplase. |
| Dabigatran etexilate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dabigatran etexilate. |
| Danaparoid | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Danaparoid. |
| Dalteparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dalteparin. |
| Tinzaparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tinzaparin. |
| (R)-warfarin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with (R)-warfarin. |
| Ethyl biscoumacetate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ethyl biscoumacetate. |
| Nadroparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Nadroparin. |
| Triflusal | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Triflusal. |
| Ticagrelor | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ticagrelor. |
| Ditazole | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Ditazole. |
| Vorapaxar | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Vorapaxar. |
| Edoxaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Edoxaban. |
| Sodium citrate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Sodium citrate. |
| Dextran | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dextran. |
| Bemiparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Bemiparin. |
| Parnaparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Parnaparin. |
| Desirudin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Desirudin. |
| Antithrombin Alfa | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Antithrombin Alfa. |
| Protein C | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Protein C. |
| Antithrombin III human | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Antithrombin III human. |
| Letaxaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Letaxaban. |
| Darexaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Darexaban. |
| Betrixaban | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Betrixaban. |
| Nafamostat | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Nafamostat. |
| Gabexate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Gabexate. |
| Fluindione | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Fluindione. |
| Protein S human | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Protein S human. |
| Brinase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Brinase. |
| Clorindione | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Clorindione. |
| Diphenadione | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Diphenadione. |
| Tioclomarol | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tioclomarol. |
| Melagatran | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Melagatran. |
| Saruplase | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Saruplase. |
| (S)-Warfarin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with (S)-Warfarin. |
| Tocopherylquinone | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tocopherylquinone. |
| Dabigatran | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dabigatran. |
| Semuloparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Semuloparin. |
| Troxerutin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Troxerutin. |
| Edetic acid | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Edetic acid. |
| Reviparin | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Reviparin. |
| Dermatan sulfate | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Dermatan sulfate. |
| SR-123781A | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with SR-123781A. |
| Limaprost | The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Limaprost. |